Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00226-6/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsmi=290054570&_hsenc=p2ANqtz--40mYYDOWmNWUPqfJYwC3wgfVrrQuOvpsqCvKfw4N3IfnCwd5GBV6C7gEhTGxbS91dGMeWO4ILVTASBmHbL6WY_Eo5Hw&utm_content=289772554&utm_source=hs_email